References
- Robert JN, Yu-Jin J. Immunity to tuberculosis. Annu Rev Immunol 2004;22:599–623.
- Kazionny B, Wells CD, Kluge H, Gusseynova N, Molotilov V. Implications of the growing HIV-1 epidemic for tuberculosis control in Russia. Lancet 2001;358:1513–1514.
- Morozova I, Riekstina V, Sture G, Wells C, Leimane V. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Int J Tuberc Lung Dis 2003;7:903–906.
- Sbarbaro JA. ‘Multidrug’-resistant tuberculosis. It is time to focus on the private sector of medicine. Chest 1997;111:1149–1151.
- Fujiwara PI, Cook SV, Rutherford CM, Crawford JT, Glickman SE, Kreiswirth BN et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med 1997;157:531–536.
- Schaberg T, Gloger G, Reichert B, Mauch H, Lode H. Resistant lung tuberculosis in Berlin 1987–1993. Pneumologie 1996;50:21–27.
- Blair IA, Mansilla Tinoco R, Brodie MJ, Clare RA, Dollery CT, Timbrell JA et al. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Hum Toxicol 1985;4:195–202.
- Ali MA, Shaharyar M, Siddiqui AA. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives. Eur J Med Chem 2007;42:268–275.
- Ali MA, Yar MS, Hasan MZ, Ahsan MJ, Pandian S. Design, synthesis and evaluation of novel 5,6-dimethoxy-1-oxo-2,3-dihydro-1H-2-indenyl-3,4-substituted phenyl methanone analogues. Bioorg Med Chem Lett 2009;19:5075–5077.
- Ali MA, Samy JG, Manogaran E, Sellappan V, Hasan MZ, Ahsan MJ et al. Synthesis and antimycobacterial evaluation of novel 5,6-dimethoxy-1-oxo-2,5-dihydro-1H-2-indenyl-5,4-substituted phenyl methanone analogues. Bioorg Med Chem Lett 2009;19:7000–7002.
- Küçükgüzel SG, Rollas S. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. Farmaco 2002;57:583–587.
- Ali MA, Shaharyar M. Oxadiazole mannich bases: Synthesis and antimycobacterial activity. Bioorg Med Chem Lett 2007;17:3314–3316.
- Shaharyar M, Ali MA, Bakht MA, Murugan V. Synthesis and antimycobacterial activity of 4-[5-(substituted phenyl)-4, 5-dihydro-3-isoxazolyl]-2-methylphenols. J Enzyme Inhib Med Chem 2008;23:432–436.
- Ragavan RV, Vijayakumar V, Kumari NS. Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles. Eur J Med Chem 2010;45:1173–1180.
- Heifets LB, Flory MA, Lindholm-Levy PJ. Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against mycobacterium tuberculosis? Antimicrob Agents Chemother 1989;33:1252–1254.
- Gundersen LL, Nissen-Meyer J, Spilsberg B. Synthesis and antimycobacterial activity of 6-arylpurines: The requirements for the N-9 substituent in active antimycobacterial purines. J Med Chem 2002;45:1383–1386.